CleanSpark Alert: Shareholder Class Action Survives Motion to Dismiss; Should Management be Held Accountable for Shareholder Losses? Contact Johnson Fistel
09 janv. 2023 18h03 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of CleanSpark, Inc. (NASDAQ: CLSK) against certain of its officers and directors. If...
(DCT): Johnson Fistel Investigates Proposed Sale of Duck Creek; Are Shareholders Getting a Fair Deal?
09 janv. 2023 09h35 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Duck Creek Technologies (NASDAQ: DCT)...
National Vision Shareholder Investigation: Submit Your Losses to Johnson Fistel
07 janv. 2023 11h17 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether National Vision Holdings, Inc. (NASDAQ: EYE), any of its executive officers, or...
Li Auto Inc. Shareholder Investigation: Submit Your Losses to Johnson Fistel
07 janv. 2023 10h46 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Li Auto Inc. (NASDAQ: LI), any of its executive officers, or others violated...
Enovix Corp. Class Action Alert: Submit Your Losses to Johnson Fistel
07 janv. 2023 09h28 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Enovix Corp. (NASDAQ:...
Mobiquity Completes Financing to Help Fund the Launch of New Publisher Focused Platform for Monetization and Compliance
05 janv. 2023 08h00 HE
|
Mobiquity Technologies, Inc.
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (Nasdaq: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technologies, is...
Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD
04 janv. 2023 06h45 HE
|
Cingulate Inc.
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in San Francisco KANSAS CITY, Kan., Jan. 04,...
F45 Class Action Deadline Alert: Johnson Fistel Encourages Shareholders to Submit Their FXLV Losses
08 déc. 2022 17h23 HE
|
Johnson Fistel, LLP
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of F45 Training Holdings, Inc....
Cingulate Benzinga All Live Access Appearance Rescheduled for December 16
01 déc. 2022 14h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate to Participate in Benzinga All Live Access Event
30 nov. 2022 15h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...